Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-05-12 | New | $48,174,992 | $48,174,992 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Peter Di Laura | Director |
Vivek Garipalli | Director |
Nick Olsen | Director |
Cheng Zhang | Director, Executive |